GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
40.33 +0.33  +0.82% NYSE Apr 23, 20:00 Delayed 2m USD

GlaxoSmithKline Total Liabilities (Quarterly):

71.48B for Dec. 31, 2017
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

GlaxoSmithKline Historical Total Liabilities (Quarterly) Data

View and export this data going back to 1986. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Dec. 31, 2017 71.48B
Sept. 30, 2017 72.46B
June 30, 2017 70.01B
March 31, 2017 66.93B
Dec. 31, 2016 66.48B
Sept. 30, 2016 71.02B
June 30, 2016 71.89B
March 31, 2016 68.89B
Dec. 31, 2015 66.03B
Sept. 30, 2015 66.36B
June 30, 2015 68.51B
March 31, 2015 68.99B
Dec. 31, 2014 55.59B
Sept. 30, 2014 56.12B
June 30, 2014 54.53B
March 31, 2014 53.72B
Dec. 31, 2013 56.52B
Sept. 30, 2013 55.46B
June 30, 2013 53.07B
March 31, 2013 53.60B
Dec. 31, 2012 56.15B
Sept. 30, 2012 54.25B
June 30, 2012 53.78B
March 31, 2012 49.82B
Dec. 31, 2011 49.70B
   
Sept. 30, 2011 51.74B
June 30, 2011 52.47B
March 31, 2011 52.53B
Dec. 31, 2010 50.14B
Sept. 30, 2010 50.59B
June 30, 2010 50.07B
March 31, 2010 50.29B
Dec. 31, 2009 51.94B
Sept. 30, 2009 50.90B
June 30, 2009 45.98B
March 31, 2009 44.09B
Dec. 31, 2008 45.52B
Sept. 30, 2008 46.43B
June 30, 2008 49.53B
March 31, 2008 41.93B
Dec. 31, 2007 41.94B
Sept. 30, 2007 35.79B
June 30, 2007 31.69B
March 31, 2007 31.89B
Dec. 31, 2006 31.14B
Sept. 30, 2006 30.78B
June 30, 2006 32.27B
March 31, 2006 32.84B
Dec. 31, 2005 33.75B
Sept. 30, 2005 32.68B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

GSK Total Liabilities (Quarterly) Benchmarks

Benchmarks
AstraZeneca 46.71B
Sanofi 49.87B
Allergan 44.50B

GSK Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 53.07B Jun 2013
Maximum 72.46B Sep 2017
Average 63.90B

GSK Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("GSK", "liabilities")
  • Last 5 data points: =YCS("GSK", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.